CORT vs ROL · P/E 199, rev $675.0M vs P/E 41, rev $3.39B
Corcept Therapeutics Incorporated (CORT) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the CORT and ROL stock pages for the full models.
Not investment advice.